Taylor Fiveash
Primary Care · Valdosta, GANPI 1962922427
Payments from drug & device makers
What this record shows
22 manufacturers reported payments, led by Atricure, Inc. at 36.2% of the total. Reporting peaked in 2023 at $4,546 and has fallen 96.1% since, to $179 in 2025. Among primary care clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 90 payments — averaging $67.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$2K
- Medtronic$2K
- Novo Nordisk$206
- Johnson & Johnson$200
- Boston Scientific$191
- AstraZeneca$186
- plus $1K from 16 others
What the payments were for
- Travel & lodging$2,93948%
- Food & beverage$3,14152%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 10 | $2,200 |
| Medtronic | 18 | $1,943 |
| Novo Nordisk | 2 | $206 |
| Johnson & Johnson | 4 | $200 |
| Boston Scientific | 6 | $191 |
| AstraZeneca | 7 | $186 |
| AbbVie | 2 | $179 |
| E.r. Squibb & Sons, L.L.C. | 6 | $149 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $125 |
| Lilly USA, LLC | 1 | $106 |
| Merck | 6 | $98 |
| Amgen | 5 | $90 |
| Boehringer Ingelheim | 4 | $88 |
| Ironshore Pharmaceuticals Inc. | 1 | $78 |
| Pfizer | 4 | $63 |
| Novartis | 3 | $53 |
| Alnylam Pharmaceuticals Inc. | 2 | $34 |
| Bayer | 2 | $30 |
| Genentech USA, Inc. | 1 | $21 |
| GSK | 1 | $19 |
| Vital Connect, Inc | 1 | $12 |
| Esperion Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$1,975
- Micra$1,334
- ATRICLIP LAA EXCLUSION SYSTEM$988
- XARELTO$153
- Ozempic$125
- VRAYLAR$125
- WATCHMAN Access System$111
- Reveal LINQ$108
- MOUNJARO$106
How this compares
$6,080 in reported general payments places this provider in the 90th percentile of 235 primary care providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 30 | $313 |
| Fluticasone Propionate | 18 | $181 |
| Cephalexin | 17 | $125 |
| Flecainide Acetate | 13 | $102 |
| Methylprednisolone | 11 | $74 |
| Lisinopril | 11 | $18 |
Paid to pharmacies, not to this prescriber.
Other primary care in Valdosta
- Pamela TurkDouglas$15K
- Morgan JonesLawrenceville$14K
- Jessi HaleColumbus$13K
- Meredith CarrAugusta$12K
- Ashtyn ZaryckiSavannah$12K
- Zanetta BryantNewnan$11K
- Hannah CummingsSuwanee$9K
- Michelle LadewigGainesville$7K
- Lucia OcanoviciuCanton$7K
- Sarah NewGrovetown$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.